Back to search
FDAFDA · Food and drugs·Recall number D-0853-2026

Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC 0409-5820-11, Carton NDC 0409-5820-01.

Published September 23, 2026 · Recall initiated: September 4, 2026

Summary

FDA records drug Class II recall D-0853-2026, published September 23, 2026 and initiated September 4, 2026. Recalling firm: Pfizer; Status: Ongoing; Reported quantity: N/A; Lot: Lot # NL5230, Exp Date:10/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email if DOPAMINE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DOPAMINE HYDROCHLORIDE
Manufacturer
Pfizer
Distributor
US Nationwide.
Lot
Lot # NL5230, Exp Date:10/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC 0409-5820-11, Carton NDC 0409-5820-01. recalled?

Yes. FDA published recall D-0853-2026 on September 23, 2026. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DOPAMINE HYDROCHLORIDE.